- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Primary axillary hyperhidrosis
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 778.9KB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 214.9KB)
Glycopyrronium – November 2025
Glycopyrronium: Cream containing glycopyrronium (as bromide) 8 mg per g (2.2 mg per actuation), 50 g; Axhidrox® - November 2025
Last updated
5 November 2025